Life Sciences Regulatory Attorney Alison Fethke Joins Epstein Becker Green, Strengthening Firm's FDA and Compliance Capabilities

Epstein Becker Green announced today that Alison Fethke has joined the firm's Health Care and Life Sciences practice as a Member of the Firm in Chicago. She is a Chambers USA-recognized attorney with extensive experience advising med tech and biopharmaceutical companies on complex regulatory compliance, fraud and abuse and Food and Drug Administration (FDA) requirements, and government investigations. Fethke joins from Ropes & Gray.

Navigating federal regulations remains a top priority for biopharmaceutical and medical device manufacturers. The Department of Justice recently reported over $6.8 billion in health care fraud settlements and judgments under the False Claims Act in 2025, underscoring the strict oversight and intense scrutiny these organizations face. Fethke provides the strategic guidance needed to navigate this complex landscape, drawing on her background as Division Counsel for Legal Regulatory & Compliance at a leading biopharmaceutical company.

"We know that clients will depend on Alison for her skill in structuring compliant commercial arrangements and navigating complex FDA requirements,” said Amy Dow, a Chair of Epstein Becker Green's Health Care & Life Sciences Steering Committee. “Alison’s firsthand industry experience will help us continue to deliver exceptional value to pharmaceutical and medical device companies facing increasingly complex regulatory challenges."

"I'm excited to contribute to the firm's legacy of excellence while helping life sciences companies translate complex legal and regulatory requirements into practical, sustainable solutions that enable innovation and reduce risk," said Fethke.

Alison specifically assists clients by:

• providing advice on complex regulatory compliance, fraud and abuse and FDA requirements for product commercialization;

• strategically managing enforcement risks under the Anti-Kickback Statute and various state laws for sales and marketing arrangements;

• supporting health care institutions during government investigations and resolutions including negotiating corporate integrity agreements; and
• assisting with development and enhancement of effective compliance programs.

To learn more about navigating these regulatory challenges, visitors can explore Epstein Becker Green's extensive resources regarding FDA compliance capabilities.

In summary, Epstein Becker Green continues to expand its national footprint with the strategic addition of Fethke. For life sciences companies, success involves translating complex legal requirements into practical, actionable programs, and Fethke’s previous industry experience enables organizations to innovate while minimizing significant regulatory risks.

Related Epstein Becker Green Resources

• Advising on the Food, Drug, and Cosmetic Act (FDCA), Public Health Service Act, and related statutes.

• Addressing legal and regulatory requirements for pharmaceutical and biotechnology manufacturers.

• Counseling on clinical trial compliance and research misconduct.
• Guiding government pricing, price reporting, and reimbursement.

About Epstein Becker Green

Epstein Becker Green is a national law firm focused on health care and life sciences; employment, labor, and workforce management; and litigation and business disputes. Our attorneys advise clients at every stage of their business lifecycle, delivering practical, results-driven counsel that shapes strategy, accelerates growth, and safeguards what matters most. We serve organizations of every size, from emerging startups to Fortune 100 companies, across the health care, life sciences, financial services, retail, hospitality, and technology industries, with sound legal solutions they can depend on when it counts. www.ebglaw.com